Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Celadon Pharmaceuticals (CEL)

Sector:

Alternative Investment Instruments

Index:

FTSE AIM All-Share

13.75p

Change Today:

-1.75p
52 Week High: 125.00p
52 Week Low: 12.06p

Currency: UK Pounds
Shares Issued: 68.85m
Volume: 332,250

Market Cap: £9.47m
RiskGrade: 111
Beta: 0.11

Trade now with Barclays Stockbrokers

Update - Celadon Pharmaceuticals is down today can you capitalise from spread betting? Find out more
Update - Celadon Pharmaceuticals is a top faller in its sector - can you take advantage with spread betting? Find out more

CEL Overview

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism and multiple sclerosis. The Company's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control.

1 Day Chart

6 Month Chart

More Celadon Pharmaceuticals charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-7908.0%	n/a
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	126.2	n/a
Pr/Book	3.0

	Latest	F'cast
Revenue	212.5%	n/a
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

CEL Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Aug-19	n/a	(0.19)	(3.60)p	n/a	n/a	n/a	n/a	0.0%
31-Aug-20	n/a	(0.17)	(2.85)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	n/a	(4.80)	(7.87)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	0.02	(18.12)	(29.70)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	0.07	(7.52)	(11.50)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CEL Company Announcements

Update on Financial Position	18-Nov-2024	07:00	RNS
New Sales Contract with a Healthcare Company	02-Oct-2024	07:00	RNS
Departure of Chief Financial Officer	30-Sep-2024	07:05	RNS

More Celadon Pharmaceuticals cel company announcements

CEL ShareCast News

Celadon Pharmaceuticals finance chief to step down	30-Sep-2024	ShareCast
Celadon inks partnership with Denmark's Valeos	11-Sep-2024	ShareCast
Celadon confident in seeing through funding chal...	23-Aug-2024	ShareCast

More Celadon Pharmaceuticals ShareCast news

Latest CEL Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

CEL Market Data

Currency	UK Pounds
Share Price	13.75p
Change Today	-1.75p
% Change	-11.29 %
52 Week High	125.00p
52 Week Low	12.06p
Volume	332,250
Shares Issued	68.85m
Market Cap	£9.47m
Beta	0.11
RiskGrade	111